Log In
BCIQ
Print this Print this
 

CMX157

  Manage Alerts
Collapse Summary General Information
Company Chimerix Inc.
DescriptionOral lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the antiviral agent tenofovir diphosphate
Molecular Target Viral polymerase
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$168.5M

$17.5M

$151.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/18/2014

Undisclosed

0

Undisclosed

07/24/2012

$168.5M

$17.5M

$151.0M

Get a free BioCentury trial today